Frequently Asked Questions What is Alka Lean
Light-headedness a feeling of faintness or unsteadiness is the type most commonly linked to dieting
Dietary supplementation with glycine to Phase-II HSB increased concentrations of guanidinoacetate in the plasma by 15% and 31%, respectively (Table 1)
Another study on Semaglutide for weight management also reported similar findings, with a minority of participants experiencing GERD symptoms
timeline spans roughly 2021 to 2024 FDA-approved GLP-1 options / Semaglutide 2.4 mg (Wegovy, approved June 2021) and tirzepatide 15 mg (Zepbound, approved November 2023) STEP-1 mean weight loss / 14.9% body-weight reduction at 68 weeks with semaglutide 2.4 mg vs
Clinical Study data from 2025 found that 10% of patients experienced muscle pain from tirzepatide, highlighting that muscle-specific complaints are the most frequently reported category, even though they still affect a minority